BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25728771)

  • 1. MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP.
    Ichikawa K; Kubota Y; Nakamura T; Weng JS; Tomida T; Saito H; Takekawa M
    Mol Cell; 2015 Apr; 58(1):35-46. PubMed ID: 25728771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus.
    Papadopoulou V; Postigo A; Sánchez-Tilló E; Porter AC; Wagner SD
    Biochem J; 2010 Apr; 427(3):541-50. PubMed ID: 20175752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
    Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
    Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.
    Sánchez-Tilló E; Lázaro A; Torrent R; Cuatrecasas M; Vaquero EC; Castells A; Engel P; Postigo A
    Oncogene; 2010 Jun; 29(24):3490-500. PubMed ID: 20418909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas.
    Peña C; García JM; García V; Silva J; Domínguez G; Rodríguez R; Maximiano C; García de Herreros A; Muñoz A; Bonilla F
    Int J Cancer; 2006 Nov; 119(9):2098-104. PubMed ID: 16804902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
    Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
    J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin.
    van Grunsven LA; Michiels C; Van de Putte T; Nelles L; Wuytens G; Verschueren K; Huylebroeck D
    J Biol Chem; 2003 Jul; 278(28):26135-45. PubMed ID: 12714599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cell maturation is accompanied by induction of N-cadherin and the transcriptional regulators of epithelial-mesenchymal transition ZEB1/2.
    Konradi S; Yasmin N; Haslwanter D; Weber M; Gesslbauer B; Sixt M; Strobl H
    Eur J Immunol; 2014 Feb; 44(2):553-60. PubMed ID: 24165969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCRIP1 promotes the expression of lung-surfactant proteins in mice by disrupting CtBP-mediated epigenetic gene silencing.
    Weng JS; Nakamura T; Moriizumi H; Takano H; Yao R; Takekawa M
    Commun Biol; 2019; 2():227. PubMed ID: 31240265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a function of CtBP in epithelial gene regulation and anoikis.
    Grooteclaes ML; Frisch SM
    Oncogene; 2000 Aug; 19(33):3823-8. PubMed ID: 10949939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated histone modifications mediated by a CtBP co-repressor complex.
    Shi Y; Sawada J; Sui G; Affar el B; Whetstine JR; Lan F; Ogawa H; Luke MP; Nakatani Y; Shi Y
    Nature; 2003 Apr; 422(6933):735-8. PubMed ID: 12700765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
    Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of corepressor function by nuclear NADH.
    Zhang Q; Piston DW; Goodman RH
    Science; 2002 Mar; 295(5561):1895-7. PubMed ID: 11847309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZEB1 imposes a temporary stage-dependent inhibition of muscle gene expression and differentiation via CtBP-mediated transcriptional repression.
    Siles L; Sánchez-Tilló E; Lim JW; Darling DS; Kroll KL; Postigo A
    Mol Cell Biol; 2013 Apr; 33(7):1368-82. PubMed ID: 23339872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corepressor CtBP and nuclear speckle protein Pnn/DRS differentially modulate transcription and splicing of the E-cadherin gene.
    Alpatov R; Shi Y; Munguba GC; Moghimi B; Joo JH; Bungert J; Sugrue SP
    Mol Cell Biol; 2008 Mar; 28(5):1584-95. PubMed ID: 18086895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
    Sinh ND; Endo K; Miyazawa K; Saitoh M
    Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
    Tryndyak VP; Beland FA; Pogribny IP
    Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.